Trump-Backed Drug to Be Tested on Thousands in Mumbai Slums
(Bloomberg) -- India’s financial capital Mumbai is fine-tuning a plan to administer an unproven but much touted anti-malarial drug in neighborhoods including Asia’s most crowded slum, the first-of-its-kind mass experiment to ward off the coronavirus. The city officials are identifying a target group which will receive hydroxychloroquine, according to Suresh…
